Table 1. Stratification of cohort into HIV-1 disease progression groupings.
No of Individuals | Range of CD4 counts utilised per person | Median annual CD4 count change (Interquartile range) | Cut-off CD4 T-cells per µl/year | Stratification group | |
Undjusted1 | Adjusted2 | ||||
7 | 8–18 | −113 (−116 to −102) | −118 (−119 to −109) | <−101 | 1 |
8 | 10–17 | −81 (−89 to −75) | −88 (−95 to −86) | −91 to +10 | 2 |
78 | 10–27 | −24 (−47 to −13) | −38 (−58 to −29) | 3 | |
3 | 20–21 | +10 (10 to 10) | −0 (−10 to −0) | 4 | |
14 | 14–24 | +24 (20 to 46) | +9 (5 to 19) | >16 | 5 |
CD4+ T cell decline without adjusting for first CD4 count and age of the participant.
CD4+ T cell decline after adjusting for first CD4 count and age of the participant.
Table 1 illustrates the stratification of 110 chronically HIV-1 adults into distinct progression groups. Six-monthly retrospective CD4 counts were used in a multilevel regression model to derive individual participant CD4 slopes. The slopes were calculated over a median observation time of 610 months (minimum-maximum 18–97 months). Annual CD4+ T-cell changes are expressed as medians with interquartile ranges. Positive (+) symbols indicate increasing CD4+ counts while (−) indicates decreasing CD4+ counts over time. Individuals in the extreme stratification group 1 were selected as rapid progressors (RP, n = 7) while those in group 5 were selected as slow progressors (SP, n = 14). Groups 2, 4and 4 were categorised as normal progressors (NP, n = 89). Normal progressors were those with CD4 slopes between −91/year to +10/year; RPs had CD4 slopes <−91/year while SPs had CD4 slopes >+10/year.